Status:

COMPLETED

Prevention of High Altitude Pulmonary Edema

Lead Sponsor:

University of Zurich

Conditions:

High Altitude Pulmonary Edema

Eligibility:

All Genders

18-60 years

Phase:

PHASE1

PHASE2

Brief Summary

A double-blind placebo controlled study * To compare the effect of tadalafil and dexamethasone versus placebo on Ppa and pulmonary edema formation in subjects susceptible to HAPE. * To investigate th...

Eligibility Criteria

Inclusion

  • At least one previous episode of high altitude pulmonary edema

Exclusion

  • pulmonary arterial hypertension
  • congenital heart disease
  • any chronic lung disease

Key Trial Info

Start Date :

July 1 2003

Trial Type :

INTERVENTIONAL

End Date :

September 1 2003

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT00274430

Start Date

July 1 2003

End Date

September 1 2003

Last Update

December 4 2006

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Prevention of High Altitude Pulmonary Edema | DecenTrialz